Literature DB >> 24879974

Loop diuretic resistance in heart failure: resistance etiology-based strategies to restoring diuretic efficacy.

Zachary L Cox1, Daniel J Lenihan2.   

Abstract

Loop diuretics are a cornerstone of symptom management for nearly all patients with heart failure. Diuretic resistance is a clinical problem with similar presentation despite diverse and multiple etiologies. Although the exact incidence is not known, diuretic resistance occurs frequently and can increase the length of hospitalization. Despite the prevalence of loop diuretic prescription in heart failure and frequency of diuretic resistance, current heart failure guidelines provide nonspecific guidance on strategies to restore diuretic efficacy. Providers are left with many questions regarding the optimum diuretic titration strategy in the setting of diuretic resistance. In light of these highly prevalent uncertainties, we present a case vignette-structured literature review of the mechanisms of diuretic resistance and recommend therapeutic strategies based on the resistance etiology to improve diuretic response in acute decompensated heart failure.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiology; acute heart failure

Mesh:

Substances:

Year:  2014        PMID: 24879974     DOI: 10.1016/j.cardfail.2014.05.007

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  7 in total

Review 1.  The short-term and long-term effects of tolvaptan in patients with heart failure: a meta-analysis of randomized controlled trials.

Authors:  Bo Xiong; Yuwen Huang; Jie Tan; Yuanqing Yao; Chunbin Wang; Jun Qian; Shunkang Rong; Shimin Deng; Yin Cao; Yanke Zou; Jing Huang
Journal:  Heart Fail Rev       Date:  2015-11       Impact factor: 4.214

Review 2.  Loop diuretic resistance complicating acute heart failure.

Authors:  Zachary L Cox; Jeffrey M Testani
Journal:  Heart Fail Rev       Date:  2020-01       Impact factor: 4.214

3.  Serum and Urine Albumin and Response to Loop Diuretics in Heart Failure.

Authors:  Antonios Charokopos; Matthew Griffin; Veena S Rao; Lesley Inker; Krishna Sury; Jennifer Asher; Jeffrey Turner; Devin Mahoney; Zachary L Cox; F Perry Wilson; Jeffrey M Testani
Journal:  Clin J Am Soc Nephrol       Date:  2019-04-22       Impact factor: 8.237

4.  Echocardiographic characteristics of patients with acute heart failure requiring tolvaptan: a retrospective study.

Authors:  Yasuki Nakada; Satoshi Okayama; Tomoya Nakano; Tomoya Ueda; Kenji Onoue; Yukiji Takeda; Rika Kawakami; Manabu Horii; Shiro Uemura; Shinichi Fujimoto; Yoshihiko Saito
Journal:  Cardiovasc Ultrasound       Date:  2015-06-08       Impact factor: 2.062

5.  A pharmacogenetic investigation of intravenous furosemide in decompensated heart failure: a meta-analysis of three clinical trials.

Authors:  S de Denus; J L Rouleau; D L Mann; G S Huggins; T P Cappola; S H Shah; J Keleti; Y F Zada; S Provost; A Bardhadi; M S Phillips; V Normand; I Mongrain; M-P Dubé
Journal:  Pharmacogenomics J       Date:  2016-03-01       Impact factor: 3.550

Review 6.  Acute Heart Failure Management.

Authors:  Kamilė Čerlinskaitė; Tuija Javanainen; Raphaël Cinotti; Alexandre Mebazaa
Journal:  Korean Circ J       Date:  2018-06       Impact factor: 3.243

Review 7.  Pharmacological and Non-pharmacological Strategies for Volume Overload in Acute Decompensated Congestive Heart Failure: A Review Article.

Authors:  Meer R Zafar; Timothy W Miller; Syed Farrukh Mustafa; Nawfal Al-Khafaji
Journal:  Cureus       Date:  2020-02-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.